|
Adiloğlu, A., N. Gönülateş, M. Işler and A. Senol (2013). "The effect of kefir consumption on human immune system: a cytokine study." Mikrobiyoloji Bulteni 47(2): 273-281. Ahmed, Z., Y. Wang, A. Ahmad, S. T. Khan, M. Nisa, H. Ahmad and A. Afreen (2013). "Kefir and health: a contemporary perspective." Crit Rev Food Sci Nutr 53(5): 422-434. Alm, L. (1982). "Effect of fermentation on lactose, glucose, and galactose content in milk and suitability of fermented milk products for lactose intolerant individuals." J Dairy Sci 65(3): 346-352. Arnett, T. (2003). "Bone structure and bone remodelling." London: University College London: pp. 1-10. Betts, J. G. (2013). Anatomy and physiology. Houston, Texas: OpenStax College, Rice University. pp. 203-231. Bilezikian, J., M. Davidson, S. Hendrix, L. Liu and M. Louie (2005). Co-morbidity of decreased bone mineral density (BMD) and increased cholesterol levels among women aged 65 years and older: Results from NHANES III. J Bone Miner Res 20(9): S219-S219. Bourassa, P., P. M. Milos, B. Gaynor, J. L. Breslow and R. J. Aiello (1996). "Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice." Proc Natl Acad Sci 93(19): 10022-10027. Brasil, G. A., M. A. Silva-Cutini, F. S. A. Moraes, T. M. C. Pereira, E. C. Vasquez, D. Lenz, N. S. Bissoli, D. C. Endringer, E. M. de Lima, V. C. Biancardi, J. F. Maia and T. U. de Andrade (2018). "The benefits of soluble non-bacterial fraction of kefir on blood pressure and cardiac hypertrophy in hypertensive rats are mediated by an increase in baroreflex sensitivity and decrease in angiotensin-converting enzyme activity." Nutrition 51-52: 66-72. Brodeur, M. R., L. Brissette, L. Falstrault, P. Ouellet and R. Moreau (2008). "Influence of oxidized low-density lipoproteins (LDL) on the viability of osteoblastic cells." Free Radic Biol Med 44(4): 506-517. Burkhardt, R. (2015). "Hyperlipidemia and cardiovascular disease: reinforcement for ''lower is better''." Curr Opin Lipidol 26(5): 468-469. Campbell, G. M. and A. Sophocleous (2014). "Quantitative analysis of bone and soft tissue by micro-computed tomography: applications to ex vivo and in vivo studies." Bonekey Rep 3: 564. Chatrou, M. L., C. P. Reutelingsperger and L. J. Schurgers (2011). "Role of vitamin K-dependent proteins in the arterial vessel wall." Hamostaseologie 31(4): 251-257. Chen, H. L., T. C. Tsai, Y. C. Tsai, J. W. Liao, C. C. Yen and C. M. Chen (2016). "Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic fatty liver disease in a murine model by modulation of inflammation and the JAK2 signaling pathway." Nutr Diabetes 6(12): e237. Chen, H. L., Y. T. Tung, C. L. Tsai, C. W. Lai, Z. L. Lai, H. C. Tsai, Y. L. Lin, C. H. Wang and C. M. Chen (2014). "Kefir improves fatty liver syndrome by inhibiting the lipogenesis pathway in leptin-deficient ob/ob knockout mice." Int J Obes (Lond) 38(9): 1172-1179. Chen, H. L., Y. T. Tung, C. H. Chuang, M. Y. Tu, T. C. Tsai, S. Y. Chang and C. M. Chen (2015). "Kefir improves bone mass and microarchitecture in an ovariectomized rat model of postmenopausal osteoporosis." Osteoporos Int 26(2): 589-599. Chesnut, C. H., 3rd, M. Azria, S. Silverman, M. Engelhardt, M. Olson and L. Mindeholm (2008). "Salmon calcitonin: a review of current and future therapeutic indications." Osteoporos Int 19(4): 479-491. Clark, D. P. and C. T. Badea (2014). "Micro-CT of rodents: state-of-the-art and future perspectives." Phys Med 30(6): 619-634. Clarke, B. (2008). "Normal bone anatomy and physiology." Clin J Am Soc Nephrol 3 (Suppl 3): S131-139. Coller, B. S. (2005). "Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?" Arterioscler Thromb Vasc Biol 25(4): 658-670. Czamanski, R., D. Greco and J. Wiest (2004). "Evaluation of antibiotic activity in filtrates of traditional kefir." Higiene Alimentar 18(124): 75-77. Dale, K. M., C. M. White, N. N. Henyan, J. Kluger and C. I. Coleman (2007). "Impact of statin dosing intensity on transaminase and creatine kinase." Am J Med 120(8): 706-712. de Guia, R. M. and S. Herzig (2015). "How do glucocorticoids regulate lipid metabolism?" Adv Exp Med Biol 872: 127-144. Demer, L. L. and Y. Tintut (2008). "Vascular calcification: pathobiology of a multifaceted disease." Circulation 117(22): 2938-2948. Doherty, T. M., K. Asotra, L. A. Fitzpatrick, J.-H. Qiao, D. J. Wilkin, R. C. Detrano, C. R. Dunstan, P. K. Shah and T. B. Rajavashisth (2003). "Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads." Proc Natl Acad Sci 100(20): 11201-11206. Domon, T., R. Suzuki, K. Takata, Y. Yamazaki, S. Takahashi, T. Yamamoto and M. Wakita (2001). "The nature and function of mononuclear cells on the resorbed surfaces of bone in the reversal phase during remodeling." Ann Anat 183(2): 103-110. Durham, A. L., M. Y. Speer, M. Scatena, C. M. Giachelli and C. M. Shanahan (2018). "Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness." Cardiovasc Res 114(4): 590-600. Elliott, J. and S. Dover (1982). "X‐ray microtomography." J Microsc 126(2): 211-213. Emini Veseli, B., P. Perrotta, G. R. A. De Meyer, L. Roth, C. Van der Donckt, W. Martinet and G. R. Y. De Meyer (2017). "Animal models of atherosclerosis." Eur J Pharmacol 816: 3-13. Farnworth, E. R. (2005). "Kefir–a complex probiotic." Food Sci Technol Bull: Fu, 2(1), 1-17. Fathi, Y., N. Ghodrati, M. J. Zibaeenezhad and S. Faghih (2017). "Kefir drink causes a significant yet similar improvement in serum lipid profile, compared with low-fat milk, in a dairy-rich diet in overweight or obese premenopausal women: A randomized controlled trial." J Clin Lipidol 11(1): 136-146. Feng, X. (2009). "Chemical and biochemical basis of cell-bone matrix interaction in health and disease." Curr Chem Biol 3(2): 189-196. Florencio-Silva, R., G. R. Sasso, E. Sasso-Cerri, M. J. Simoes and P. S. Cerri (2015). "Biology of bone tissue: structure, function, and factors that influence bone cells." Biomed Res Int 2015: 421746. Friques, A. G., C. M. Arpini, I. C. Kalil, A. L. Gava, M. A. Leal, M. L. Porto, B. V. Nogueira, A. T. Dias, T. U. Andrade, T. M. Pereira, S. S. Meyrelles, B. P. Campagnaro and E. C. Vasquez (2015). "Chronic administration of the probiotic kefir improves the endothelial function in spontaneously hypertensive rats." J Transl Med 13: 390. Garrote, G. L., A. G. Abraham and G. L. De Antoni (2010). "Microbial interactions in kefir: a natural probiotic drink." Biotechnol Lactic Acid Bacteria: Novel Applications 18: 327-340. Gaschler, M. M. and B. R. Stockwell (2017). "Lipid peroxidation in cell death." Biochem Biophys Res Commun 482(3): 419-425. Gaware, V., K. Kotade, R. Dolas, K. Dhamak, S. Somwnshis, V. Nikam and V. Kashid (2011). "The magic of kefir: a review." Pharmacol Online 1: 376-386. Goetz, L. G., R. Mamillapalli, C. Sahin, M. Majidi-Zolbin, G. Ge, A. Mani and H. S. Taylor (2018). "Addition of estradiol to cross-sex testosterone therapy reduces atherosclerosis plaque formation in female ApoE-/- mice." Endocrinology 159(2): 754-762. Grishina, A., I. Kulikova, L. Alieva, A. Dodson, I. Rowland and J. Jin (2011). "Antigenotoxic effect of kefir and ayran supernatants on fecal water-induced DNA damage in human colon cells." Nutr Cancer 63(1): 73-79. Güven, A., A. Güven and M. Gülmez (2003). "The effect of kefir on the activities of GSH‐Px, GST, CAT, GSH and LPO levels in carbon tetrachloride‐induced mice tissues." J Vet Med B 50(8): 412-416. Guzel-Seydim, Z. B., T. Kok-Tas, A. K. Greene and A. C. Seydim (2011). "Review: functional properties of kefir." Crit Rev Food Sci Nutr 51(3): 261-268. Hadisaputro, S., R. Djokomoeljanto and M. Soesatyo (2012). "The effects of oral plain kefir supplementation on proinflammatory cytokine properties of the hyperglycemia Wistar rats induced by streptozotocin." Acta Med Indones 44(100): e4. Harper, R. P. and E. Fung (2007). "Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]." J Oral Maxillofac Surg 65(3): 573-580. Hekimsoy, Z. (2008). "Osteocytes-the known and unknown." Turkish J Endocrinol Metab 12(1): 23-27. Hemingway, F., R. Taylor, H. Knowles and N. Athanasou (2011). "RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II." Bone 48(4): 938-944. Hertzler, S. R. and S. M. Clancy (2003). "Kefir improves lactose digestion and tolerance in adults with lactose maldigestion." J Am Diet Assoc 103(5): 582-587. Hirasawa, H., S. Tanaka, A. Sakai, M. Tsutsui, H. Shimokawa, H. Miyata, S. Moriwaki, S. Niida, M. Ito and T. Nakamura (2007). "ApoE gene deficiency enhances the reduction of bone formation induced by a high-fat diet through the stimulation of p53-mediated apoptosis in osteoblastic cells." J Bone Miner Res 22(7): 1020-1030. Hjortnaes, J., J. Butcher, J. L. Figueiredo, M. Riccio, R. H. Kohler, K. M. Kozloff, R. Weissleder and E. Aikawa (2010). "Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation." Eur Heart J 31(16): 1975-1984. Hong, W., X. Y. Xu, Z. H. Qiu, J. J. Gao, Z. Y. Wei, L. Zhen, X. L. Zhang and Z. B. Ye (2015). "Sirt1 is involved in decreased bone formation in aged apolipoprotein E-deficient mice." Acta Pharmacol Sinica 36(12): 1487. Horák, P., M. Skácelová and A. Kazi (2017). "Role of strontium ranelate in the therapy of osteoporosis." J Rheum Dis Treat 3(2): 1-6. Hounsfield, G. N. (1973). "Computerized transverse axial scanning (tomography): Part 1. Description of system." Br J Radiol 46(552): 1016-1022. Huang, M. S., J. Lu, Y. Ivanov, A. P. Sage, W. Tseng, L. L. Demer and Y. Tintut (2008). "Hyperlipidemia impairs osteoanabolic effects of PTH." J Bone Miner Res 23(10): 1672-1679. Huseini, H. F., G. Rahimzadeh, M. R. Fazeli, M. Mehrazma and M. Salehi (2012). "Evaluation of wound healing activities of kefir products." Burns 38(5): 719-723. Ishibashi, S., M. S. Brown, J. L. Goldstein, R. D. Gerard, R. E. Hammer and J. Herz (1993). "Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery." J Clin Invest 92(2): 883-893. Kalra, M. K., A. D. Sodickson and W. W. Mayo-Smith (2015). "CT radiation: key concepts for gentle and wise use." Radiographics 35(6): 1706-1721. Kanbak, G., K. Uzuner, K. Kusat Ol, A. Oglakci, K. Kartkaya and H. Senturk (2014). "Effect of kefir and low-dose aspirin on arterial blood pressure measurements and renal apoptosis in unhypertensive rats with 4 weeks salt diet." Clin Exp Hypertens 36(1): 1-8. Kapinas, K. and A. M. Delany (2011). "MicroRNA biogenesis and regulation of bone remodeling." Arthritis Res Ther 13(3): 220. Kawano, Y. and D. E. Cohen (2013). "Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease." J Gastroenterol 48(4): 434-441. Kawashima, H., Y. Nakajima, Y. Matubara, J. Nakanowatari, T. Fukuta, S. Mizuno, S. Takahashi, T. Tajima and T. Nakamura (1997). "Effects of vitamin K2 (menatetrenone) on atherosclerosis and blood coagulation in hypercholesterolemic rabbits." Jpn J Pharmacol 75(2): 135-143. Khoury, N., S. El-Hayek, O. Tarras, M. El-Sabban, M. El-Sibai and S. Rizk (2014). "Kefir exhibits antiproliferative and proapoptotic effects on colon adenocarcinoma cells with no significant effects on cell migration and invasion." Int J Oncol 45(5): 2117-2127. Kim, D. H., H. Kim, D. Jeong, I. B. Kang, J. W. Chon, H. S. Kim, K. Y. Song and K. H. Seo (2017). "Kefir alleviates obesity and hepatic steatosis in high-fat diet-fed mice by modulation of gut microbiota and mycobiota: targeted and untargeted community analysis with correlation of biomarkers." J Nutr Biochem 44: 35-43. Kreel, L. (1991). "Medical imaging." Postgrad Med J 67(786): 334-346. Kurnatowska, I., P. Grzelak, A. Masajtis-Zagajewska, M. Kaczmarska, L. Stefańczyk, C. Vermeer, K. Maresz and M. Nowicki (2015). "Effect of vitamin K." Pol Arch Intern Med 125(9): 631-640. Lai, S. W., K. F. Liao, H. C. Lai, P. Y. Tsai, C. L. Lin, P. C. Chen and F. C. Sung (2013). "Risk of major osteoporotic fracture after cardiovascular disease: a population-based cohort study in Taiwan." J Epidemiol 23(2): 109-114. Lim, J., M. Kale, D. H. Kim, H. S. Kim, J. W. Chon, K. H. Seo, H. G. Lee, W. Yokoyama and H. Kim (2017). "Antiobesity effect of exopolysaccharides isolated from kefir grains." J Agric Food Chem 65(46): 10011-10019. Linton, M. F., P. G. Yancey, S. S. Davies, W. G. J. Jerome, E. F. Linton and K. C. Vickers (2015). "The role of lipids and lipoproteins in atherosclerosis." Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK343489/ Liu, J. R., Y. Y. Lin, M. J. Chen, L. J. Chen and C. W. Lin (2005). "Antioxidative activities of kefir." Asian-Aust. J. Anim. Sci 18(4): 567-573. Liu, M., W. Zhang, X. Li, J. Han, Y. Chen and Y. Duan (2016a). "Impact of age and sex on the development of atherosclerosis and expression of the related genes in apoE deficient mice." Biochem Biophys Res Commun 469(3): 456-462. Liu, Y., M. Almeida, R. S. Weinstein, C. A. O''Brien, S. C. Manolagas and R. L. Jilka (2016b). "Skeletal inflammation and attenuation of Wnt signaling, Wnt ligand expression, and bone formation in atherosclerotic ApoE-null mice." Am J Physiol Endocrinol Metab 310(9): E762-E773. Maeda, H., X. Zhu, K. Omura, S. Suzuki and S. Kitamura (2004). "Effects of an exopolysaccharide (kefiran) on lipids, blood pressure, blood glucose, and constipation." Biofactors 22(1‐4): 197-200. Maki, R., M. Matsukawa, A. Matsuduka, M. Hashinaga, H. Anai, Y. Yamaoka, K. Hanada and C. Fujii (2018). "Therapeutic effect of lyophilized, Kefir-fermented milk on constipation among persons with mental and physical disabilities." Jpn J Nurs Sci 15(3): 218-225. Marcus, R., D. W. Dempster and M. L. Bouxsein (2013). The nature of osteoporosis. Osteoporosis (Fourth Edition), Elsevier, California, USA: pp. 21-30. Marshall, V. M. and W. M. Cole (1985). "Methods for making kefir and fermented milks based on kefir." J Dairy Res 52(3): 451-456. McClung, M. R., E. M. Lewiecki, S. B. Cohen, M. A. Bolognese, G. C. Woodson, A. H. Moffett, M. Peacock, P. D. Miller, S. N. Lederman and C. H. Chesnut (2006). "Denosumab in postmenopausal women with low bone mineral density." N Engl J Med 354(8): 821-831. Mert, H., H. Yilmaz, K. Irak, S. Yildirim and N. Mert (2018). "Investigation of the protective effect of kefir against isoproterenol induced myocardial infarction in rats." Korean J Food Sci Anim Resour 38(2): 259-272. Meyers, M. A., P. Y. Chen, A. Y. M. Lin and Y. Seki (2008). "Biological materials: Structure and mechanical properties." Prog Mater Sci 53(1): 1-206. Morgan, E. F., G. L. Barnes and T. A. Einhorn (2013). The bone organ system: form and function. Osteoporosis (Fourth Edition), Elsevier, California, USA: pp. 3-20. Nair, A. B. and S. Jacob (2016). "A simple practice guide for dose conversion between animals and human." J Basic Clin Pharm 7(2): 27-31. Nelson, R. H. (2013). "Hyperlipidemia as a risk factor for cardiovascular disease." Prim Care 40(1): 195-211. Nie, P., D. Li, L. Hu, S. Jin, Y. Yu, Z. Cai, Q. Shao, J. Shen, J. Yi, H. Xiao, L. Shen and B. He (2014). "Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors." PLoS One 9(5): e97009. O''Brien, P. and A. C. Marshall (2015). "Coarctation of the aorta." Circulation 131(9): e363-365. Okuyama, H., P. H. Langsjoen, T. Hamazaki, Y. Ogushi, R. Hama, T. Kobayashi and H. Uchino (2015). "Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms." Expert Rev Clin Pharmacol 8(2): 189-199. Oliver, W. C. and G. M. Pharr (1992). "An improved technique for determining hardness and elastic modulus using load and displacement sensing indentation experiments." J Mater Res 7(6): 1564-1583. Organization, W. H., P. H. A. o. Canada and C. P. H. A. o. Canada (2005). Preventing chronic diseases: a vital investment, World Health Organization. Oryan, A., E. Alemzadeh and M. H. Eskandari (2018). "Kefir accelerates burn wound healing through inducing fibroblast cell migration in vitro and modulating the expression of IL-1ss, TGF-ss1, and bFGF genes in vivo." Probiotics Antimicrob Proteins doi:10.1007/s12602-018-9435-6. Osako, M. K., H. Nakagami, N. Koibuchi, H. Shimizu, F. Nakagami, H. Koriyama, M. Shimamura, T. Miyake, H. Rakugi and R. Morishita (2010). "Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification." Circ Res 107(4): 466-475. Ostadrahimi, A., A. Taghizadeh, M. Mobasseri, N. Farrin, L. Payahoo, Z. B. Gheshlaghi and M. Vahedjabbari (2015). "Effect of probiotic fermented milk (kefir) on glycemic control and lipid profile in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial." Iran J Public Health 44(2): 228. Parto, P., C. J. Lavie, D. Swift and X. Sui (2015). "The role of cardiorespiratory fitness on plasma lipid levels." Expert Rev Cardiovasc Ther 13(11): 1177-1183. Parvez, S., K. A. Malik, S. Ah Kang and H. Y. Kim (2006). "Probiotics and their fermented food products are beneficial for health." J Appl Microbiol 100(6): 1171-1185. Pendse, A. A., J. M. Arbones-Mainar, L. A. Johnson, M. K. Altenburg and N. Maeda (2009). "Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond." J Lipid Res 50 (Suppl): S178-182. Persy, V. and P. D’Haese (2009). "Vascular calcification and bone disease: the calcification paradox." Trends Mol Med 15(9): 405-416. Piedrahita, J. A., S. H. Zhang, J. R. Hagaman, P. M. Oliver and N. Maeda (1992). "Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells." Proc Nat Acad Sci 89(10): 4471-4475. Pirih, F., J. Lu, F. Ye, O. Bezouglaia, E. Atti, M. G. Ascenzi, S. Tetradis, L. Demer, T. Aghaloo and Y. Tintut (2012). "Adverse effects of hyperlipidemia on bone regeneration and strength." J Bone Miner Res 27(2): 309-318. Pogačić, T., S. Šinko, Š. Zamberlin and D. Samaržija (2013). "Microbiota of kefir grains." Mljekarstvo 63(1): 3-14. Raggatt, L. J. and N. C. Partridge (2010). "Cellular and molecular mechanisms of bone remodeling." J Biol Chem 285(33): 25103-25108. Ralston, S. H. (2013). "Bone structure and metabolism." Medicine 41(10): 581-585. Reid, I. R. (2008). "Anti-resorptive therapies for osteoporosis." Semin Cell Dev Biol 19(5): 473-478. Riggs, B. L. and L. C. Hartmann (2003). "Selective estrogen-receptor modulators—mechanisms of action and application to clinical practice." N Engl J Med 348(7): 618-629. Rodrigues, K., J. Carvalho and J. Schneedorf (2005a). "Anti-inflammatory properties of kefir and its polysaccharide extract." Inflammopharmacology 13(5): 485-492. Rodrigues, K. L., L. R. Caputo, J. C. Carvalho, J. Evangelista and J. M. Schneedorf (2005b). "Antimicrobial and healing activity of kefir and kefiran extract." Int J Antimicrob Agents 25(5): 404-408. Rosa, D. D., M. M. S. Dias, L. M. Grzeskowiak, S. A. Reis, L. L. Conceicao and M. Peluzio (2017). "Milk kefir: nutritional, microbiological and health benefits." Nutr Res Rev 30(1): 82-96. Sage, A. P., J. Lu, E. Atti, S. Tetradis, M. G. Ascenzi, D. J. Adams, L. L. Demer and Y. Tintut (2011). "Hyperlipidemia induces resistance to PTH bone anabolism in mice via oxidized lipids." J Bone Miner Res 26(6): 1197-1206. Sage, A. P., Y. Tintut and L. L. Demer (2010). "Regulatory mechanisms in vascular calcification." Nat Rev Cardiol 7(9): 528-536. Santanna, A. F., P. F. Filete, E. M. Lima, M. L. Porto, S. S. Meyrelles, E. C. Vasquez, D. C. Endringer, D. Lenz, D. S. P. Abdalla, T. M. C. Pereira and T. U. Andrade (2017). "Chronic administration of the soluble, nonbacterial fraction of kefir attenuates lipid deposition in LDLr(-/-) mice." Nutrition 35: 100-105. Sarkar, S. (2008). "Biotechnological innovations in kefir production: a review." Br Food J 110(3): 283-295. Schaffler, M. B. and O. D. Kennedy (2012). "Osteocyte signaling in bone." Curr Osteoporos Rep 10(2): 118-125. Schierwagen, R., L. Maybüchen, S. Zimmer, K. Hittatiya, C. Bäck, S. Klein, F. E. Uschner, W. Reul, P. Boor and G. Nickenig (2015). "Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis." Sci Rep 5: 12931. Schoppet, M., J. R. Schaefer and L. C. Hofbauer (2003). "Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in men." Circulation 107(11): e76. Schulz, E., K. Arfai, X. Liu, J. Sayre and V. Gilsanz (2004). "Aortic calcification and the risk of osteoporosis and fractures." J Clin Endocrinol Metab 89(9): 4246-4253. Schurgers, L. J. (2013). "Vitamin K: key vitamin in controlling vascular calcification in chronic kidney disease." Kidney Int 83(5): 782-784. Shao, J. S., S. L. Cheng, J. Sadhu and D. A. Towler (2010). "Inflammation and the osteogenic regulation of vascular calcification: a review and perspective." Hypertension 55(3): 579-592. Shobeiri, N. and M. P. Bendeck (2017). Interleukin-1β is a key biomarker and mediator of inflammatory vascular calcification, American Heart Association, Inc: 179-180. Sirtori, C. R. (2014). "The pharmacology of statins." Pharmacol Res 88: 3-11. Steinl, D. C. and B. A. Kaufmann (2015). "Ultrasound imaging for risk assessment in atherosclerosis." Int J Mol Sci 16(5): 9749-9769. Su, F. C., C. C. Wu and S. Chien (2011). "Roles of microenvironment and mechanical forces in cell and tissue remodeling." J Med Biol Eng 31: 233-244. Suriasih, K., W. R. Aryanta, G. Mahardika and N. M. Astawa (2012). "Microbiological and chemical properties of Kefir made of Bali cattle milk." Food Sci Qual Manag 6: 2225-0557. Szulc, P., D. P. Kiel and P. D. Delmas (2008). "Calcifications in the abdominal aorta predict fractures in men: MINOS study." J Bone Miner Res 23(1): 95-102. Tamai, Y., N. Yoshimitsu, Y. Watanabe, Y. Kuwabara and S. Nagai (1996). "Effects of milk fermented by culturing with various lactic acid bacteria and a yeast on serum cholesterol level in rats." J Ind Microbiol Biotechnol 81(2): 181-182. Taylor, F. C., M. Huffman and S. Ebrahim (2013). "Statin therapy for primary prevention of cardiovascular disease." JAMA 310(22): 2451-2452. Teitelbaum, S. L. (2000). "Bone resorption by osteoclasts." Science 289(5484): 1504-1508. Thomas, J., T. Shentu and D. K. Singh (2012). Cholesterol: biosynthesis, functional diversity, homeostasis and regulation by natural products. Biochemistry, InTech. 18: 419-442. Thompson, P. D., G. Panza, A. Zaleski and B. Taylor (2016). "Statin-associated side effects." J Am Coll Cardiol 67(20): 2395-2410. Tomkin, G. H. and D. Owens (2012). "The chylomicron: relationship to atherosclerosis." Int J Vasc Med 2012: 784536. Tsou, Y. A., H. J. Huang, T. C. Wang, C. J. Tai, C. M. Chen and C. Y. C. Chen (2014). "Evaluation of correlation of cell cycle proteins and Ki-67 interaction in paranasal sinus inverted papilloma prognosis and squamous cell carcinoma transformation." Biomed Res Int 2014: (634945). Tu, M. Y., H. L. Chen, Y. T. Tung, C. C. Kao, F. C. Hu and C. M. Chen (2015). "Short-term effects of kefir-fermented milk consumption on bone mineral density and bone metabolism in a randomized clinical trial of osteoporotic patients." PLoS One 10(12): e0144231. Tung, Y. T., H. L. Chen, H. S. Wu, M. H. Ho, K. Y. Chong and C. M. Chen (2018). "Kefir peptides prevent hyperlipidemia and obesity in high-fat-diet-induced obese rats via lipid metabolism modulation." Mol Nutr Food Res 62(3) doi: 10.1002/mnfr.201700505. Vinderola, G., G. Perdigon, J. Duarte, D. Thangavel, E. Farnworth and C. Matar (2006). "Effects of kefir fractions on innate immunity." Immunobiology 211(3): 149-156. Wen, S. T., W. Chen, H. L. Chen, C. W. Lai, C. C. Yen, K. H. Lee, S. C. Wu and C. M. Chen (2013). "Amniotic fluid stem cells from EGFP transgenic mice attenuate hyperoxia-induced acute lung injury." PLoS One 8(9): e75383. Wilkinson, M. J., L. J. Laffin and M. H. Davidson (2014). "Overcoming toxicity and side-effects of lipid-lowering therapies." Best Pract Res Clin Endocrinol Metab 28(3): 439-452. Wu, W., L. Zhao, P. Yang, W. Zhou, B. Li, J. F. Moorhead, Z. Varghese, X. Z. Ruan and Y. Chen (2016). "Inflammatory stress sensitizes the liver to atorvastatin-induced injury in ApoE-/-mice." PLoS One 11(7): e0159512. Yamamoto, C., N. Fukuda, M. Jumabay, K. Saito, T. Matsumoto, T. Ueno, M. Soma, K. Matsumoto and T. Shimosawa (2011). "Protective effects of statin on cardiac fibrosis and apoptosis in adrenomedullin-knockout mice treated with angiotensin II and high salt loading." Hyperten Res 34(3): 348. Yamane, T., T. Sakamoto, T. Nakagaki and Y. Nakano (2018). "Lactic acid bacteria from kefir increase cytotoxicity of natural killer cells to tumor cells." Foods 7(4): 48. Yan, P., C. Xia, C. Duan, S. Li and Z. Mei (2011). "Biological characteristics of foam cell formation in smooth muscle cells derived from bone marrow stem cells." Int J Biol Sci 7(7): 937. Zeng, Y., J. Wu, X. He, L. Li, X. Liu and X. Liu (2017). "Mechanical microenvironment regulation of age-related diseases involving degeneration of human skeletal and cardiovascular systems." Prog Biophys Mol Biol. pii: S0079-6107(17)30175-X. doi: 10.1016/j.pbiomolbio.2017.09.022. Zhang, Y. and B. Feng (2017). "Systematic review and meta‐analysis for the association of bone mineral density and osteoporosis/osteopenia with vascular calcification in women." Int J Rheum Dis 20(2): 154-160. Zhang, Y. B., Z. M. Zhong, G. Hou, H. Jiang and J. T. Chen (2011). "Involvement of oxidative stress in age-related bone loss." J Surg Res 169(1): e37-e42. 余傑明, 吳岱穎, 楊榮森, 廖振焜, 樓亞洲 和 陳建志 (2012). "骨質疏鬆症的藥物治療." 台灣老年醫學暨老年學雜誌 7(2): 77-90. 洪尚平 和 王啟忠 (2014). "美國心臟醫學會高膽固醇血症治療新概念." 家庭醫學與基層醫療 29(10): 262-266.
|